Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Alpha-blockers are the most effective and widely used treatment for lower urinary tract symptoms, with minimal side effects.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Naltrexone did not significantly reduce hair pulling but improved cognitive flexibility.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

MR antagonists may improve skin health and wound healing, especially in aging.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Activating TRPV3 reduces skin oil production and increases inflammation, potentially causing dry skin issues.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.